Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of Glimepiride in Type 2 Diabetes and Chronic Heart Failure (GLID-HF)
NCT07288749Phase 3Not yet recruiting
- Sponsor
- Tongji Hospital
- Start
- Jan 2026
- Primary completion
- Dec 2030
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of glimepiride in type 2 diabetes mellitus (T2DM), chronic heart failure (CHF), sponsored by Tongji Hospital. Planned start Jan 2026; status: not yet recruiting.
02
Drugs
glimepiride
03
Conditions
type 2 diabetes mellitus (T2DM)chronic heart failure (CHF)
Beyond the preview
Go deeper on NCT07288749.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07288749.